Anthony S. Gibney

Insider Reports History

Entity
Individual
Location
C/O Achillion Pharmaceuticals, Inc., 300 George Street, New Haven, CT
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anthony S. Gibney:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Clearside Biomedical, Inc. Director Common Stock 100K $130K $1.30 Apr 18, 2024 Direct
Clearside Biomedical, Inc. Director Stock Option (right to buy) 45K Jun 20, 2024 Direct
IVERIC bio, Inc. EVP, Chief Business Officer Common Stock 0 $39.45 Jul 11, 2023 Direct
IVERIC bio, Inc. EVP, Chief Business Officer Restricted Stock Units 0 Jul 11, 2023 Direct
IVERIC bio, Inc. EVP, Chief Business Officer Stock Option (Right to Buy) 0 $10.03 Jul 11, 2023 Direct

Insider Reports Filed by Anthony S. Gibney

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLSD Clearside Biomedical, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
CLSD Clearside Biomedical, Inc. Apr 17, 2024 2 $130K 4 Apr 19, 2024 Director
CLSD Clearside Biomedical, Inc. Apr 15, 2024 1 $0 4 Apr 16, 2024 Director
CLSD Clearside Biomedical, Inc. Apr 15, 2024 0 $0 3 Apr 16, 2024 Director
ISEE IVERIC bio, Inc. Jul 11, 2023 6 $0 4 Jul 13, 2023 EVP, Chief Business Officer
ISEE IVERIC bio, Inc. Jun 28, 2023 1 $0 4 Jun 30, 2023 EVP, Chief Business Officer
ISEE IVERIC bio, Inc. Dec 20, 2022 2 $0 4 Dec 22, 2022 EVP, Chief Business Officer
ISEE IVERIC bio, Inc. Dec 13, 2022 4 $0 4 Dec 14, 2022 EVP, Chief Business Officer
ISEE IVERIC bio, Inc. Jun 30, 2022 3 -$73.3K 4 Jul 5, 2022 EVP, Chief Business Officer
ISEE IVERIC bio, Inc. Dec 13, 2021 4 $0 4 Dec 15, 2021 EVP, Chief Business Officer
ISEE IVERIC bio, Inc. Dec 13, 2021 0 $0 3 Dec 15, 2021 EVP, Chief Business Officer